Table 1.
Association of PSAT1 Expression with Clinicopathological Features in EOC Patients
| Variable | Low PSAT1 Expression (n=45) | High PSAT1 Expression (n=45) | P |
|---|---|---|---|
| n (%) | n (%) | ||
| Age (years) | |||
| <50 | 12(26.7) | 13(28.9) | 0.814 |
| ≥50 | 33(73.3) | 32(71.1) | |
| Histological subtype | |||
| Other | 9(20.0) | 2(4.4) | 0.024 |
| Serous | 36(80.0) | 43(95.6) | |
| FIGO stage | |||
| I–II | 31(68.9) | 10(22.2) | 0.000 |
| III–IV | 14(31.1) | 35(77.8) | |
| Histological grade | |||
| Low | 10(22.2) | 2(4.4) | 0.013 |
| High | 35(77.8) | 43(95.6) | |
| Tumor size (cm3) | |||
| <1000 | 39(86.7) | 38(84.4) | 0.764 |
| ≥1000 | 6(13.3) | 7(15.6) | |
| Number of tumors | |||
| <2 | 24(53.3) | 28(62.2) | 0.393 |
| ≥2 | 21(46.7) | 17(37.8) | |
| Residual tumor diameter (cm) | |||
| <1 | 43(95.6) | 41(91.1) | 0.398 |
| ≥1 | 2(4.4) | 4(8.9) | |
| Lymph node metastasis | |||
| Absent | 38(84.4) | 24(53.3) | 0.001 |
| Present | 7(15.6) | 21(46.7) | |
| Distant metastasis | |||
| Absent | 43(95.6) | 37(82.2) | 0.044 |
| Present | 2(4.4) | 8(17.8) | |
| CA125 level (U/mL) | |||
| <600 | 29(64.4) | 23(51.1) | 0.200 |
| ≥600 | 16(35.6) | 22(48.9) | |
| Ascites | |||
| Absent | 23(51.1) | 12(26.7) | 0.017 |
| Present | 22(48.9) | 33(73.3) | |